Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-31

Clinical Trial Update: Oral Immunotherapy for Wheat Allergy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on oral immunotherapy for wheat allergy across Phase 1 and Phase 2, completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral immunotherapy for wheat allergy

Snippet

Sponsor: Hugh A Sampson, MD | Conditions: Wheat Allergy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-03-31